Technical Analysis for CGIX - Cancer Genetics, Inc.

Grade Last Price % Change Price Change
grade C 3.23 0.62% 0.02
CGIX closed up 0.62 percent on Friday, June 5, 2020, on 1.49 times normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CGIX trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Calm After Storm Range Contraction 0.00%
Crossed Above 200 DMA Bullish 0.62%
Bollinger Band Squeeze Range Contraction 0.62%
Calm After Storm Range Contraction 0.62%
Inside Day Range Contraction 0.62%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Cancer Genetics, Inc., an early-stage diagnostics company, focuses on the development and commercialization of proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to treatment of cancer. The company offers a range of services in various areas, including microarray based testing, a proprietary microarray test for the detection of chromosomal abnormalities observed in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma and Diffuse Large B-cell Lymphoma; molecular testing to analyze DNA and RNA to follow progression of disease and response to therapy at the genetic level; cytogenetics testing, a series of methods for analyzing human chromosomes to identify malignancy; fish testing, an analysis of abnormalities at the chromosomal and gene levels; flow cytometry testing, an immuno pheno - type analysis of specific markers inside cells; histology testing, a microscopic examination of stained tissue sections; cytology testing, a non-gynecological fluid preparation for microscopic evaluations by a pathologist; and IHC testing, an analysis of the distribution of tumor antigens in specific cell and tissue types. It offers DNA-based cancer diagnostics and services medical institutions. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also provides a range of non-proprietary oncology-focused tests and laboratory services that offer critical genomic information to healthcare professionals, as well as biopharma and biotech. The company was founded in 1999 and is headquartered in Rutherford, New Jersey.
Cancer Biology Disease Treatment Of Cancer Cancers Molecular Biology Tumor Lymphoma Healthcare Professionals Chronic Lymphocytic Leukemia Laboratory Services Anatomical Pathology Human Papillomavirus Infection Cytogenetics Dna Chip Fluorescence In Situ Hybridization Pathology

Is CGIX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.5
52 Week Low 0.085
Average Volume 39,511
200-Day Moving Average 3.13
50-Day Moving Average 3.03
20-Day Moving Average 3.06
10-Day Moving Average 3.11
Average True Range 0.26
ADX 12.08
+DI 22.27
-DI 12.85
Chandelier Exit (Long, 3 ATRs ) 2.86
Chandelier Exit (Short, 3 ATRs ) 3.49
Upper Bollinger Band 3.31
Lower Bollinger Band 2.80
Percent B (%b) 0.84
BandWidth 16.89
MACD Line 0.04
MACD Signal Line 0.01
MACD Histogram 0.0268
Fundamentals Value
Market Cap 63.92 Million
Num Shares 19.8 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -3.17
Price-to-Sales 1.94
Price-to-Book 2.87
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.61
Resistance 3 (R3) 3.57 3.42 3.54
Resistance 2 (R2) 3.42 3.32 3.43 3.52
Resistance 1 (R1) 3.32 3.26 3.36 3.36 3.50
Pivot Point 3.17 3.17 3.18 3.18 3.17
Support 1 (S1) 3.07 3.07 3.11 3.11 2.96
Support 2 (S2) 2.92 3.01 2.93 2.94
Support 3 (S3) 2.82 2.92 2.92
Support 4 (S4) 2.86